|
by Hans R. Larsen, MSc ChE
There are good fats and there are bad fats. Artificially
produced trans-fatty acids are bad in any amount and saturated
fats from animal products should be kept to a minimum.
The best fats or oils rather, since they are liquid
at room temperature, are those that contain the essential
fatty acids so named because without them we die. Essential
fatty acids are polyunsaturated and grouped into two families,
the omega-6 EFAs and the omega-3 EFAs.
Seemingly minor differences in their
molecular structure make the two EFA families act very
differently in the body. While the metabolic products
of omega-6 acids promote inflammation, blood clotting,
and tumor growth, the omega-3 acids act entirely opposite.
Although we do need both omega-3s and
omega-6s it is becoming increasingly clear that an excess of omega-6 fatty acids can have
dire consequences.
Many scientists believe that a major
reason for the high incidence of heart disease, hypertension,
diabetes, obesity, premature aging, and some forms of
cancer is the profound imbalance between our intake of
omega-6 and omega-3 fatty acids.
Our ancestors evolved on a diet with
a ratio of omega-6 to omega-3 of about 1:1. A massive
change in dietary habits over the last few centuries has
changed this ratio to something closer to 20:1 and this
spells trouble. [1-3]
Sources and requirements
The main sources of omega-6 fats are
vegetable oils such as corn oil and soy oil that contain
a high proportion of linoleic acid. Omega-3 fats are found
in flaxseed oil, walnut oil, and marine plankton and fatty
fish.
The main component of flaxseed and walnut
oils is alpha-linolenic acid while the predominant fatty
acids found in fatty fish and fish oils are eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA).
Grassfed
Beef is higher in Omega 3 than fish
Normally a good ratio for omega 6:3
in fish is 2 or 3 to 1. The lower the better. Grassfed
beef from Grassfed Organics is much higher in Omega 3
than fish, with a 6:3 ratio
of 0.16 to 1. This information is from a study
done at Iowa State University in August 2001.
The most
beneficial and active of these fatty acids are EPA and
DHA.
Alpha-linolenic acid can be converted
to EPA and DHA in the body, but the conversion is quite
inefficient especially in older people. [1, 2]
Scientists were first alerted to the
many benefits of EPA and DHA in the early 1970s when Danish
physicians observed that Greenland Eskimos had an exceptionally
low incidence of heart disease and arthritis despite the
fact that they consumed a high-fat diet.
Intensive research soon discovered that
two of the fats (oils) they consumed in large quantities,
EPA and DHA, were actually highly beneficial. More recent
research has established that fish oils (EPA and DHA)
play a crucial role in the prevention of atherosclerosis,
heart attack, depression, and cancer.
Clinical trials have shown that fish
oil supplementation is effective in the treatment of many
disorders including rheumatoid arthritis, diabetes, ulcerative
colitis, and Raynaud's disease. [1-5]
Recognizing the unique benefits of EPA
and DHA and the serious consequences of a deficiency the
US National Institutes of Health recently published Recommended
Daily Intakes of fatty acids. They recommend a total daily
intake of 650 mg
of EPA and DHA, 2.22 g/day of alpha-linolenic acid and
4.44 g/day of linoleic acid. Saturated fat intake should
not exceed 8 per cent of total calorie intake or about
18 g/day.
Good for the brain and children too
The human brain is one of the largest
"consumers" of DHA. A normal adult human brain contains
more than 20 grams of DHA. Low DHA levels have been linked
to low brain serotonin levels which again are connected
to an increased tendency to depression, suicide, and violence.
A high intake of fish has been linked
to a significant decrease in age-related memory loss and
cognitive function impairment and a lower risk of developing
Alzheimer's disease. A recent study found that Alzheimer's
patients given an omega-3-rich supplement experienced a significant improvement in their quality
of life.[6-9]
Several studies have established a clear
association between low levels of omega-3 fatty acids
and depression. Other studies have shown that countries
with a high level of fish consumption have fewer cases
of depression.
Researchers at Harvard Medical School
have successfully used fish oil supplementation to treat
bipolar disorder (manic-depressive illness) and British
researchers report encouraging results in the treatment
of schizophrenia. [10-15]
An adequate intake of DHA and EPA is
particularly important during pregnancy and lactation.
During this time the mother must supply all the baby's
needs for DHA and EPA because it is unable to synthesize
these essential fatty acids itself. DHA makes up 15 to
20% of the cerebral cortex and 30 to 60% of the retina
so it is absolutely necessary for normal development of
the fetus and baby.
There is some evidence that an insufficient
intake of omega-3 fatty acids may increase the risk of
premature birth and an abnormally low birth weight. There
is also emerging evidence that low levels of omega-3 acids are associated with hyperactivity
in children. [1, 3, 16- 22]
The constant drain on a mother's DHA
reserves can easily lead to a deficiency and some researchers
believe that preeclampsia (pregnancy-related high blood
pressure) and postpartum depression could be linked to
a DHA deficiency. Experts recommend that women get at
least 500-600 mg of DHA every day during pregnancy and
lactation. The easiest way to ensure this intake is to
take a good fish oil supplement daily. [17-19]
Researchers at the University of Sydney
have found that children who regularly eat fresh, oily
fish have a four times lower risk of developing asthma
than do children who rarely eat such fish. They speculate
that EPA present in the fish may prevent the development
of asthma or reduce its severity by reducing airway inflammation
and responsiveness.
Researchers at the University of Wyoming
have found that supplementation with 3.3 grams/day of
fish oil markedly reduces breathing difficulties
and other symptoms in asthma patients. Other research
has found fish oil to be beneficial in the treatment of
other lung diseases such as cystic fibrosis and emphysema.
[23- 29]
The heart's best friend
An enormous amount of medical literature
testifies to the fact that fish oils prevent and may help
to ameliorate or reverse atherosclerosis, angina, heart
attack, congestive heart failure, arrhythmias, stroke,
and peripheral vascular disease. Fish oils help maintain
the elasticity of artery walls, prevent blood clotting,
reduce blood pressure and stabilize heart rhythm. [1-4,
30-33]
Danish researchers have concluded that
fish oil supplementation may help prevent arrhythmias
and sudden cardiac death in healthy men. An Italian study
of 11,000 heart attack survivors found that patients supplementing
with fish oils markedly reduced their risk of another
heart attack, a stroke or death.
A group of German researchers found
that fish oil supplementation for 2 years caused regression
of atherosclerotic deposits and American medical researchers
report that men who consume fish once or more every week
have a 50% lower risk
of dying from a sudden cardiac event than do men who eat
fish less than once a month. [34-40]
Greek researchers report that fish oil
supplementation (10 grams/day) reduces the number of attacks
by 41% in men suffering from angina. Norwegian medical
doctors have found that fish oil supplementation reduces
the severity of a heart attack and Indian researchers
report that supplementation started immediately after
a heart attack reduces future complications.
Bypass surgery
and angioplasty patients reportedly also benefit from
fish oils and clinical trials
have shown that fish oils are safe for heart disease patients.
The evidence is indeed overwhelming. An adequate daily
intake (about 1 gram) of EPA and DHA is essential to maintain
a healthy heart. Fish oils are especially important for
diabetics who have an increased risk of heart disease.
[41- 49]
Researchers at the University of Cincinnati
have found that supplementing with as little as 2 grams/day
of fish oil (410 mg of EPA plus 285 mg of DHA) can lower
diastolic pressure by 4.4 mm Hg and systolic pressure
by 6.5 mm Hg in people with elevated blood pressure. Enough
to avoid taking drugs in cases of borderline hypertension.
Several other clinical trials have confirmed that fish
oils are indeed effective in lowering high blood pressure
and that they may work even better if combined with a
program of salt restriction. [50-55]
Reduces pain and helps prevent cancer
Fish oils are particularly effective
in reducing inflammation and can be of great benefit to
people suffering from rheumatoid arthritis or ulcerative
colitis. Daily supplementation with as little as 2.7 grams
of EPA and 1.8 grams of DHA can markedly reduce the number
of tender joints and increase the time before fatigue
sets in. Some studies have also noted a decrease in morning
stiffness and at least two clinical trials concluded that
arthritis patients who took fish oils could eliminate
or sharply reduce their use of NSAIDs and other arthritis
drugs. [56-61]
Patients with
ulcerative colitis have abnormally low blood levels of
EPA.
Clinical trials have shown that supplementation
with fish oil (2.7 grams of EPA and 1.8 grams of DHA daily)
can reduce the severity of the condition by more than
50% and enable many patients to discontinue anti-inflammatory
medication and steroids. [62-64]
There is now also considerable evidence
that fish oil consumption can delay or reduce tumor development
in breast cancer. Studies have also shown that a high
blood level of omega-3 fatty acids combined with a low
level of omega-6 acids reduces the risk of developing
breast cancer.
Daily supplementation with as little
as 2.5 grams of fish oils has been found effective in
preventing the progression from benign polyps to colon
cancer and Korean researchers recently reported that prostate
cancer patients have low blood levels of omega-3 fatty
acids. Greek researchers report that fish oil supplementation
improves survival and quality of life in terminally ill
cancer patients. [65-73]
Safe and easily available
It is estimated that 85% or more of
people in the Western world are deficient in omega-3 fatty
acids and most get far too
much of the omega-6 fatty acids. Vegetarian
diets, for example, tend to be very high in omega-6.
The recommended daily intake of EPA
plus DHA is about 650 mg rising to 1000 mg/day during
pregnancy and lactation. Clinical trials have used anywhere
from 1 g/day to 10 g/day, but little additional benefit
has been observed at levels above 5 g/day of EPA and DHA
combined.
The benefits of therapeutic supplementation
may become evident in a few weeks when blood parameters
(triglycerides, fibrinogen) are involved, but may take
3 months or longer to materialize in degenerative diseases
like atherosclerosis and rheumatoid arthritis. [74, 75]
The processing and packaging of the
fish oil are crucial in determining its quality. Low quality oils may be quite unstable
and contain significant amounts of mercury, pesticides,
and undesirable oxidation products.
High quality oils are stabilized with
adequate amounts of vitamin E and are packaged in individual
foil pouches or other packaging impervious to light and
oxygen. Some very recent research carried out at the University
of Minnesota found that emulsified fish oils are much
better absorbed than the straight oils in gelatin capsules.
[76]
Cod liver oils and fish oils are not
the same. Cod liver oil is extracted from cod liver and
is an excellent source of vitamins A and D. Fish oils
are extracted from the tissues (flesh) of fatty fish like
salmon and herring and are good sources of EPA and DHA.
Fish oils contain very little vitamin
A and D, but cod liver oil does contain EPA and DHA. However,
you would probably exceed the recommended daily intake
of vitamins A and D if you were to try to obtain therapeutic
amounts of EPA and DHA from cod liver oil.
Supplementing
with fish oils has been found to be entirely safe even for periods as long as 7 years and no significant
adverse effects have been reported in hundreds of clinical
trials using as much as 18 grams/day of fish oils. Fish
oil supplementation does, however, lower blood concentrations
of vitamin E so it is a good idea to take extra vitamin
E when adding fish oils to your diet.
A clinical trial carried out by the
US Department of Agriculture found that taking 200 mg/day
of synthetic vitamin E (equivalent to about 100 IU of
natural alpha-tocopherol) is sufficient to completely
counteract this effect of fish oil supplementation. [74,
75, 77, 78]
References
1.Simopoulos, Artemis. Omega-3 fatty acids in health
and disease and in growth and development. American Journal
of Clinical Nutrition, Vol. 54, 1991, pp. 438-63
2. Pepping, Joseph. Omega-3 essential fatty acids. American
Journal of Health-System Pharmacy, Vol. 56, April 15, 1999,
pp. 719-24
3. Uauy-Dagach, Ricardo and Valenzuela, Alfonso. Marine
oils: the health benefits of n-3 fatty acids. Nutrition
Reviews, Vol. 54, November 1996, pp. S102-S108
4. Connor, William E. Importance of n-3 fatty acids in health
and disease. American Journal of Clinical Nutrition, Vol.
71 (suppl), January 2000, pp. 171S-75S
5. DiGiacomo, Ralph A. , et al. Fish-oil Dietary Supplementation
in Patients with Raynaud's Phenomenon: A Double-Blind, Controlled,
Prospective Study. The American Journal of Medicine, Vol.
86, February 1989, pp. 158-164
6. Levine, Barbara S. Most frequently asked questions about
DHA. Nutrition Today, Vol. 32, November/December 1997, pp.
248-49
7. Kalmijn, S., et al. Polyunsaturated fatty acids, antioxidants,
and cognitive function in very old men. American Journal
of Epidemiology, Vol. 145, January 1, 1997, pp. 33-41
8. Kalmijn, S., et al. Dietary fat intake and the risk of
incident dementia in the Rotterdam Study. Annals of Neurology,
Vol. 42(5), November 1997, pp. 776-82
9. Yehuda, S., et al. Essential fatty acids preparation
(SR-3) improves Alzheimer's patients quality of life. International
Journal of Neuroscience, Vol. 87(3-4), November 1996, pp.
141-9
10. Edwards, R., et al. Omega-3 polyunsaturated fatty acid
levels in the diet and in red blood cell membranes of depressed
patients. Journal of Affective Disorders, Vol. 48, March
1998, pp. 149-55
11. Hibbeln, Joseph R. Fish consumption and major depression.
The Lancet, Vol. 351, April 18, 1998, p. 1213 (correspondence)
12. Hibbeln, Joseph R. and Salem, Norman. Dietary polyunsaturated
fatty acids and depression: when cholesterol does not satisfy.
American Journal of Clinical Nutrition, Vol. 62, July 1995,
pp. 1-9
13. Stoll, Andrew L., et al. Omega 3 fatty acids in bipolar
disorder. Archives of General Psychiatry, Vol. 56, May 1999,
pp. 407-12 and pp. 415-16 (commentary)
14. Calabrese, Joseph R., et al. Fish oils and bipolar disorder.
Archives of General Psychiatry, Vol. 56, May 1999, pp. 413-14
(commentary)
15. Laugharne, J.D.E., et al. Fatty acids and schizophrenia.
Lipids, Vol. 31 (suppl), 1996, pp. S163-S65
16. Jensen, Craig L., et al. Effect of docosahexaenoic acid
supplementation of lactating women on the fatty acid composition
of breast milk lipids and maternal and infant plasma phospholipids.
American Journal of Clinical Nutrition, Vol. 71 (suppl),
January 2000, pp. 292S-99S
17. Makrides, Maria and Gibson, Robert A. Long-chain polyunsaturated
fatty acid requirements during pregnancy and lactation.
American Journal of Clinical Nutrition, Vol. 71 (suppl),
2000, pp. 307S-11S
18. Connor, William E., et al. Increased docosahexaenoic
acid levels in human newborn infants by administration of
sardines and fish oil during pregnancy. Lipids, Vol. 31
(suppl), 1996, pp. S183-S87
19. Cunnane, S.C., et al. Breast-fed infants achieve a higher
rate of brain and whole body docosahexaenoate accumulation
than formula-fed infants not consuming dietary docosahexaenoate.
Lipids, Vol. 35, January 2000, pp. 105-11
20. Carlson, S.E., et al. Long-chain polyunsaturated fatty
acids and development of human infants. Acta Paediatr Suppl,
Vol. 88 (430), August 1999, pp. 72-7
21. Mitchell, E.A., et al. Clinical characteristics and
serum essential fatty acid levels in hyperactive children.
Clin Pediatr (Phila), Vol. 26, August 1987, pp. 406-11
22. Stevens, Laura J., et al. Essential fatty acid metabolism
in boys with attention-deficit hyperactivity disorder. American
Journal of Clinical Nutrition, Vol. 62, No. 4, October 1995,
pp. 761-68
23. Hodge, Linda, et al. Consumption of oily fish and childhood
asthma risk. Medical Journal of Australia, Vol. 164, February
5, 1996, pp. 137-40
24. Broughton, K. Shane, et al. Reduced asthma symptoms
with n-3 fatty acid ingestion are related to 5-series leukotriene
production. American Journal of Clinical Nutrition, Vol.
65, April 1997, pp. 1011-17
25. Dry, J. and Vincent, D. Effect of a fish oil diet on
asthma: results of a 1-year double-blind study. International
Archives of Allergy and Applied Immunology, Vol. 95, No.
2/3, 1991, pp. 156-7
26. Shahar, Eyal, et al. Dietary n-3 polyunsaturated fatty
acids and smoking-related chronic obstructive pulmonary
disease. The New England Journal of Medicine, Vol. 331,
No. 4, July 28, 1994, pp. 228-33
27. Lawrence, R. and Sorrell, T. Eicosapentaenoic acid in
cystic fibrosis: evidence of a pathogenetic role for leukotriene
B4. The Lancet, Vol. 342, August 21, 1993, pp. 465-69
28. Katz, D.P., et al. The use of an intravenous fish oil
emulsion enriched with omega-3 fatty acids in patients with
cystic fibrosis. Nutrition, Vol. 12, May 1996, pp. 334-39
29. Schwartz, Joel. Role of polyunsaturated fatty acids
in lung disease. American Journal of Clinical Nutrition,
Vol. 71 (suppl), January 2000, pp. 393S-96S
30. Daviglus, Martha L., et al. Fish consumption and the
30-year risk of fatal myocardial infarction. New England
Journal of Medicine, Vol. 336, April 10, 1997, pp. 1046-53
31. Christensen, Jeppe Hagstrup, et al. Effect of fish oil
on heart rate variability in survivors of myocardial infarction.
British Medical Journal, Vol. 312, March 16, 1996, pp. 677-78
32. Simon, Joel A., et al. Serum fatty acids and the risk
of coronary heart disease. American Journal of Epidemiology,
Vol. 142, No. 5, September 1, 1995, pp. 469-76
33. Flaten, Hugo, et al. Fish-oil concentrate: effects of
variables related to cardiovascular disease. American Journal
of Clinical Nutrition, Vol. 52, 1990, pp. 300-06
34. Christensen, Jeppe Hagstrup, et al. Heart rate variability
and fatty acid content of blood cell membranes: a dose-response
study with n-3 fatty acids. American Journal of Clinical
Nutrition, Vol. 70, September 1999, pp. 331-37
35. Dietary supplementation with n-3 polyunsaturated fatty
acids and vitamin E after myocardial infarction: results
of the GISSI-Prevenzione trial. The Lancet, Vol. 354, August
7, 1999, pp. 447-55
36. Brown, Morris. Do vitamin E and fish oil protect against
ischaemic heart disease? The Lancet, Vol. 354, August 7,
1999, pp. 441-42 (commentary)
37. von Schacky, Clemens, et al. The effect of dietary omega-3
fatty acids on coronary atherosclerosis. Annals of Internal
Medicine, Vol. 130, April 6, 1999, pp. 554-62
38. Albert, Christine M., et al. Fish consumption and risk
of sudden cardiac death. Journal of the American Medical
Association, Vol. 279, January 7, 1998, pp. 23-28
39. Kromhout, Daan. Fish consumption and sudden cardiac
death. Journal of the American Medical Association, Vol.
279, January 7, 1998, pp. 65-66 (editorial)
40. Siscovick, David S., et al. Dietary intake and cell
membrane levels of long-chain n-3 polyunsaturated fatty
acids and the risk of primary cardiac arrest. Journal of
the American Medical Association, Vol. 274, No. 17, November
1, 1995, pp. 1363-67
41. Salachas, A., et al. Effects of low-dose fish oil concentrate
on angina, exercise tolerance time, serum triglycerides,
and platelet function. Angiology, Vol. 45, December 1994,
pp. 1023-31
42. Landmark, K., et al. Use of fish oils appears to reduce
infarct size as estimated from peak creatine kinase and
lactate dehydrogenase activities. Cardiology, Vol. 89 (2),
1998, pp. 94- 102
43. Singh, R.B., et al. Randomized, double-blind, placebo-controlled
trial of fish oil and mustard oil in patients with suspected
acute myocardial infarction. Cardiovasc Drugs Ther, Vol.
11, July 1997, pp. 485-91
44. Eritsland, J., et al. Long-term effects of n-3 polyunsaturated
fatty acids on haemostatic variables and bleeding episodes
in patients with coronary artery disease. Blood Coagul Fibrinolysis,
Vol. 6, February 1995, pp. 17-22
45. von Schacky, Clemens. n-3 fatty acids and the prevention
of coronary atherosclerosis. American Journal of Clinical
Nutrition, Vol. 71 (suppl), January 2000, pp. S224-27S
46. Connor, William E. Diabetes, fish oil, and vascular
disease. Annals of Internal Medicine, Vol. 123, No. 12,
December 15, 1995, pp. 950-52
47. McManus, Ruth M., et al. A comparison of the effects
of n-3 fatty acids from linseed oil and fish oil in well-controlled
type II diabetes. Diabetes Care, Vol. 19, May 1996, pp.
463-67
48. Luo, Jing, et al. Moderate intake of n-3 fatty acids
for 2 months has no detrimental effect on glucose metabolism
and could ameliorate the lipid profile in type 2 diabetic
men. Diabetes Care, Vol. 21, May 1998, pp. 717-24
49. Rivellese, Angela A., et al. Long-term effects of fish
oil on insulin resistance and plasma lipoproteins in NIDDM
patients with hypertriglyceridemia. Diabetes Care, Vol.
19, November 1996, pp. 1207-13
50. Appel, Lawrence J., et al. Does supplementation of diet
with "fish oil" reduce blood pressure? Archives of Internal
Medicine, Vol. 153, June 28, 1993, pp. 1429-38
51. Radack, Kenneth, et al. The effects of low doses of
n-3 fatty acid supplementation on blood pressure in hypertensive
subjects. Archives of Internal Medicine, Vol. 151, June
1991, pp. 1173-80
52. Morris, Martha Clare, et al. Does fish oil lower blood
pressure? A meta-analysis of controlled trials. Circulation,
Vol. 88, No. 2, August 1993, pp. 523-33
53. Andreassen, A.K., et al. Hypertension prophylaxis with
omega-3 fatty acids in heart transplant recipients. J Am
Coll Cardiol, Vol. 29, May 1997, pp. 1324-31
54. Cobiac, L., et al. Effects of dietary sodium restriction
and fish oil supplements on blood pressure in the elderly.
Clin Exp Pharmacol Physiol, Vol. 18, May 1991, pp. 265-68
55. Toft, Ingrid, et al. Effects of n-3 polyunsaturated
fatty acids on glucose homeostasis and blood pressure in
essential hypertension. Annals of Internal Medicine, Vol.
123, No. 12, December 15, 1995, pp. 911-18
56. Kremer, Joel M., et al. Fish-oil fatty acid supplementation
in active rheumatoid arthritis: A double-blinded, controlled,
crossover study. Annals of Internal Medicine, Vol. 106,
April 1987, pp. 497-503
57. Kremer, Joel M. n-3 fatty acid supplements in rheumatoid
arthritis. American Journal of Clinical Nutrition, Vol.
71 (suppl), January 2000, pp. 349S-51S
58. Fortin, Paul R., et al. Validation of a meta-analysis:
the effects of fish oil in rheumatoid arthritis. Journal
of Clinical Epidemiology, Vol. 48, 1995, pp. 1379-90
59. Kremer, J.M., et al. Effects of high-dose fish oil on
rheumatoid arthritis after stopping nonsteroidal anti-inflammatory
drugs - clinical and immune correlates. Arthritis and Rheumatology,
Vol. 38, August 1995, pp. 1107-14
60. Geusens, P., et al. Long-term effect of omega-3 fatty
acid supplementation in active rheumatoid arthritis: a 12-month,
double-blind, controlled study. Arthritis and Rheumatology,
Vol. 37, June 1994, pp. 824-29
61. Navarro, Elisabet, et al. Abnormal fatty acid pattern
in rheumatoid arthritis - A rationale for treatment with
marine and botanical lipids. Journal of Rheumatology, Vol.
27, February 2000, pp. 298-303
62. Aslan, Alex and Triadafilopoulos, George. Fish oil fatty
acid supplementation in active ulcerative colitis: A double-blind,
placebo-controlled, crossover study. American Journal of
Gastroenterology, Vol. 87, April 1992, pp. 432-37
63. Salomon, P., et al. Treatment of ulcerative colitis
with fish oil n-3 omega fatty acid: an open trial. Journal
of Clinical Gastroenterology, Vol. 12, April 1990, pp. 157-61
64. Siguel, E.N. and Lerman, R.H. Prevalence of essential
fatty acid deficiency in patients with chronic gastrointestinal
disorders. Metabolism, Vol. 45, January 1996, pp. 12-23
65. Simonsen, Neal, et al. Adipose tissue omega-3 and omega-6
fatty acid content and breast cancer in the EURAMIC Study.
American Journal of Epidemiology, Vol. 147, No. 4, 1998,
pp. 342-52
66. Cave, W.T. Jr. Dietary omega-3 polyunsaturated fats
and breast cancer. Nutrition, Vol. 12 (suppl), January 1996,
pp. S39-42
67. Fernandez-Banares, F., et al. Changes of the mucosal
n3 and n6 fatty acid status occur early in the colorectal
adenoma-carcinoma sequence. Gut, Vol. 38, 1996, pp. 254-59
68. Anti, M., et al. Effects of different doses of fish
oil on rectal cell proliferation in patients with sporadic
colonic adenomas. Gastroenterology, Vol. 107, December 1994,
pp. 1709-18
69. Yang, Y.J., et al. Comparison of fatty acid profiles
in the serum of patients with prostate cancer and benign
prostatic hyperplasia. Clinical Biochemistry, Vol. 32, August
1999, pp. 405-09
70. Norrish, A.E., et al. Prostate cancer risk and consumption
of fish oils: a dietary biomarker- based case-control study.
British Journal of Cancer, Vol. 81, No. 7, December 1999,
pp. 1238-42
71. Gogos, Charalambos A., et al. Dietary omega-3 polyunsaturated
fatty acids plus vitamin E restore immunodeficiency and
prolong survival for severely ill patients with generalized
malignancy. Cancer, Vol. 82, January 15, 1998, pp. 395-402
72. Wigmore, S.J., et al. The effect of polyunsaturated
fatty acids on the progress of cachexia in patients with
pancreatic cancer. Nutrition, Vol. 12 (suppl), January 1996,
pp. S27-30
73. Barber, M.D., et al. The effect of an oral nutritional
supplement enriched with fish oil on weight-loss in patients
with pancreatic cancer. British Journal of Cancer, Vol.
81, No. 1, September 1999, pp. 80-86
74. Saynor, R. and Gillott, T. Changes in blood lipids and
fibrinogen with a note on safety in a long term study on
the effects of n-3 fatty acids in subjects receiving fish
oil supplements and followed for seven years. Lipids, Vol.
27, July 1992, pp. 533-38
75. Eritsland, Jan. Safety considerations of polyunsaturated
fatty acids. American Journal of Clinical Nutrition, Vol.
71 (suppl), January 2000, pp. 197S-201S
76. Bibus, Douglas M., et al. Bioavailability Studies of
Emulsified Flavored Fish Oil. The University of Minnesota,
Austin, MN. January 21, 2000
77. Nair, Padmanabhan P., et al. Dietary fish oil-induced
changes in the distribution of alpha- tocopherol, retinol,
and beta-carotene in plasma, red blood cells, and platelets:
modulation by vitamin E. American Journal of Clinical Nutrition,
Vol. 58, July 1993, pp. 98-102
78. Sanders, T.A.B. and Hinds, Allison. The influence of
a fish oil high in docosahexaenoic acid on plasma lipoprotein
and vitamin E concentrations and haemostatic function in
healthy male volunteers. British Journal of Nutrition, Vol
68, July 1992, pp. 163-73 |